The DOI matches its Crossref record; 278 of the 288 references it cites were found in a registry or an index.
Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients
Abstract
There is evidence that there is a bidirectional relationship between major depression and cardiovascular disorder (CVD): depressed patients are a population at risk for increased cardiac morbidity and mortality, and depression is more frequent in patients who suffer from CVD. There is also evidence that inflammatory and oxidative and nitrosative stress (IO&NS) pathways underpin the common pathophysiology of both CVD and major depression. Activation of these pathways may increase risk for both disorders and contribute to shared risk. The shared IO&NS pathways that may contribute to CVD and depression comprise the following: increased levels of pro-inflammatory cytokines, like interleukin-1β (IL-1β), IL-2, IL-6, IL-8, IL-12, tumor necrosis factor-α, and interferon-γ; T cell activation; increased acute phase proteins, like C-reactive protein, haptoglobin, fibrinogen and α1-antitrypsin; complement factors; increased LPS load through bacterial translocation and subsequent gut-derived inflammation; induction of indoleamine 2,3-dioxygenase with increased levels of tryptophan catabolites; decreased levels of antioxidants, like coenzyme Q10, zinc, vitamin E, glutathione and glutathione peroxidase; increased O&NS characterized by oxidative damage to low density lipoprotein (LDL) and phospholipid inositol, increased malondialdehyde, and damage to DNA and mitochondria; increased nitrosative stress; and decreased ω3 polyunsaturated fatty acids (PUFAs). The complex interplay between the abovementioned IO&NS pathways in depression results in pro-atherogenic effects and should be regarded as a risk factor to future clinical CVD and due mortality. We suggest that major depression should be added as a risk factor to the Charlson "comorbidity" index. It is advised that patients with (sub)chronic or recurrent major depression should routinely be assessed by serology tests to predict if they have an increased risk to cardiovascular disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering that the presence of oxidative (and nitrosative) stress may cause neurodegeneration and reduced neurogenesis [63, 64]”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [63]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144
Defining Comorbidity: Implications for Understanding Health and Health Services
Valderas, J. M., Starfield, B. H., Sibbald, B., Salisbury, C., & Roland, M. O. (2009) · The Annals of Family Medicine · doi:10.1370/afm.983 · Cited by 1,730
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
The pre-therapeutic classification of co-morbidity in chronic disease
Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
Gerszten, R. E., García-Zepeda, E. A., Lim, Y.-C., Yoshida, M., Ding, H. A., Gimbrone, M. A., Luster, A. D., Luscinskas, F. W., & Rosenzweig, A. (1999) · Nature · doi:10.1038/19546 · Cited by 1,242
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Self-citationMaes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Self-citationEvidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Self-citation
Research works printed but not linked: 2
- Maes, 1998, Fatty acids, cytokines, and major depression, Biol Psychiatry, 43, 313
- Maes, 2007, Neuro Endocrinol Lett, 28, 861
Cited by
Sorted by citations
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Self-citationA Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485
Lifestyle medicine for depression
Sarris, J., O’Neil, A., Coulson, C. E., Schweitzer, I., & Berk, M. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-107 · Cited by 450
Self-citationCan bipolar disorder be viewed as a multi-system inflammatory disease?
Leboyer, M., Soreca, I., Scott, J., Frye, M., Henry, C., Tamouza, R., & Kupfer, D. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.049 · Cited by 417
Oxidative & nitrosative stress in depression: Why so much stress?
Moylan, S., Berk, M., Dean, O. M., Samuni, Y., Williams, L. J., O'Neil, A. E., Hayley, A. C., Pasco, J. A., Anderson, G., Jacka, F. N., et al. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.05.007 · Cited by 412
Self-citationAspirin: a review of its neurobiological properties and therapeutic potential for mental illness
Berk, M., Dean, O. M., Drexhage, H. A., McNeil, J. J., Moylan, S., O'Neil, A. E., Davey, C. G., Sanna, L., & Maes, M. H. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-74 · Cited by 395
Self-citationTryptophan in health and disease
Comai, S., Bertazzo, A., Brughera, M., & Crotti, S. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.08.005 · Cited by 306
Rapaport, M. H., Nierenberg, A. A., Schettler, P. J., Kinkead, B. L., Cardoos, A., Walker, R., & Mischoulon, D. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.22 · Cited by 275
Patterns of Multimorbidity in the Aged Population. Results from the KORA-Age Study
Kirchberger, I., Meisinger, C., Heier, M., Zimmermann, A.-K., Thorand, B., Autenrieth, C. S., Peters, A., Ladwig, K., & Döring, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030556 · Cited by 256
Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-142 · Cited by 248
Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205
de Melo, Nunes, S. O. V., Anderson, G., Vargas, H. O., Barbosa, D. S., Gałecki, P., Carvalho, A. F., & Maes, M. H. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.027 · Cited by 194
Self-citationBrunoni, A. R., Kemp, A. H., Dantas, E. M., Goulart, A. C., Nunes, M. A., Boggio, P. S., Mill, J. G., Lotufo, P. A., Fregni, F., & Benseñor, I. M. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000497 · Cited by 149
Nikkheslat, N., Zunszain, P. A., Horowitz, M. A., Barbosa, I. G., Parker, J. A., Myint, A.-M., Schwarz, M. J., Tylee, A. T., Carvalho, L. A., & Pariante, C. M. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.002 · Cited by 147
Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
Anderson, G., & Maes, M. H. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660738 · Cited by 148
Self-citationPrakhinkit, S., Suppapitiporn, S., Tanaka, H., & Suksom, D. (2014) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2013.0205 · Cited by 149
The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders
Wang, T., Lee, S.-Y., Chen, S., Chung, Y.-L., Li, C., Chang, Y., Wang, L., Chen, P. S., Chen, S., Chu, C., et al. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw012 · Cited by 120
Self-citationNunes, S. O. V., de Melo, de Castro, M. R. P., Barbosa, D. S., Vargas, H. O., Berk, M., & Maes, M. H. J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.038 · Cited by 120
Self-citationA neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome
Morris, G., & Maes, M. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-012-9324-8 · Cited by 117
Self-citationShared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 118
Self-citationDietary selenium and major depression: a nested case-control study
Pasco, J. A., Jacka, F. N., Williams, L. J., Evans-Cleverdon, M., Brennan-Olsen, S. L., Kotowicz, M. A., Nicholson, G. C., Ball, M. J., & Berk, M. (2012) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2011.12.008 · Cited by 112
Self-citationLifestyle management of unipolar depression
Berk, M., Sarris, J., Coulson, C. E., & Jacka, F. N. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12124 · Cited by 111
Self-citationMaes, M. H. J., Leonard, B. E., Fernandez, A., Kubera, M., Nowak, G., Veerhuis, R., Gardner, A., Ruckoanich, P., Geffard, M., Altamura, C. A., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.019 · Cited by 103
Self-citationPasco, J. A., Williams, L. J., Jacka, F. N., Stupka, N., Brennan-Olsen, S. L., Holloway‐Kew, K. L., & Berk, M. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0279-7 · Cited by 102
Self-citationMorris, G., Puri, B. K., Bortolasci, C. C., Carvalho, A., Berk, M., Walder, K., Moreira, E. G., & Maes, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.037 · Cited by 84
Self-citationBortolasci, C. C., Vargas, H. O., Souza-Nogueira, A., Barbosa, D. S., Moreira, E. G., Nunes, S. O. V., Berk, M., Dodd, S., & Maes, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.018 · Cited by 83
Self-citationvan Zonneveld, S. M., van den Oever, E. J., Haarman, B. C. M., Grandjean, E. L., Nuninga, J. O., van de Rest, O., & Sommer, I. E. (2024) · Nutrients · doi:10.3390/nu16162646 · Cited by 88
Pro-inflammatory dietary intake as a risk factor for CVD in men: a 5-year longitudinal study
O'Neil, A. E., Shivappa, N., Jacka, F. N., Kotowicz, M. A., Kibbey, K. J., Hébert, J. R., & Pasco, J. A. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003815 · Cited by 80
Woo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010080 · Cited by 79
Almulla, A. F., Thipakorn, Y., Algon, A. A. A., Tunvirachaisakul, C., Al‐Hakeim, H. K., & Maes, M. H. J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.007 · Cited by 79
Self-citationConnecting Dots between Mitochondrial Dysfunction and Depression
Khan, M., Baussan, Y., & Hébert-Chatelain, É. (2023) · Biomolecules · doi:10.3390/biom13040695 · Cited by 77
Maes, M. H. J., Bonifácio, K. L., Morelli, N. R., Vargas, H. O., Moreira, E. G., Stoyanov, D., Barbosa, D. S., Carvalho, A. F., & Nunes, S. O. V. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9906-2 · Cited by 78
Self-citationDepression and Cardiovascular Disease: The Viewpoint of Platelets
Amadio, P., Zarà, M., Sandrini, L., Ieraci, A., & Barbieri, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207560 · Cited by 75
Gomes, C. C., Martinho, F. C., Barbosa, D. S., Antunes, L. S., Póvoa, H. C. C., Baltus, T. H. L., Morelli, N. R., Vargas, H. O., Nunes, S. O. V., Anderson, G., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0545-z · Cited by 69
Self-citationSigurdardottir, S. L., & Halldórsdóttir, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041849 · Cited by 67
Vargas, H. O., Nunes, S. O. V., Barbosa, D. S., Vargas, M. M., Cestari, A., Dodd, S., Venugopal, K., Maes, M. H. J., & Berk, M. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.02.033 · Cited by 65
Self-citation2D-DIGE proteome analysis on the platelet proteins of patients with major depression
Huang, T., Sung, M.-L., & Chen, T. (2014) · Proteome Science · doi:10.1186/1477-5956-12-1 · Cited by 66
A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression
Roomruangwong, C., Anderson, G., Berk, M., Stoyanov, D., Carvalho, A. F., & Maes, M. H. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.015 · Cited by 65
Self-citationQuirk, S. E., El-Gabalawy, R. M., Brennan-Olsen, S. L., Bolton, J. M., Sareen, J., Berk, M., Chanen, A. M., Pasco, J. A., & Williams, L. J. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0974-1 · Cited by 67
Self-citationSonei, N., Amiri, S., Jafarian, I., Anoush, M., Rahimi-Balaei, M., Bergen, H., Haj‐Mirzaian, A., & Hosseini, M. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1149218 · Cited by 59
Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
Moreira, E. G., Boll, K. M., Correia, D. G., Soares, J. F., Rigobello, C., & Maes, M. H. J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x17666181227164947 · Cited by 57
Self-citationAgomelatine in Depressive Disorders: Its Novel Mechanisms of Action
Srinivasan, V., Zakaria, R., Othman, Z., Lauterbach, E. C., & Acuña-Castroviejo, D. (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11090216 · Cited by 58
A Comparison of Inflammatory Markers in Depressed and Nondepressed Smokers
Nunes, S. O. V., Vargas, H. O., Brum, J., Prado, E., Vargas, M. M., de Castro, M. R. P., Dodd, S., & Berk, M. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr247 · Cited by 59
Self-citationHemmingsen, J. G., Möller, P., Jantzen, K., Jönsson, B., Albin, M. C., Wierzbicka, A., Gudmundsson, A., Loft, S. H., & Rissler, J. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2015.03.009 · Cited by 52
Simeonova, D., Stoyanov, D., Leunis, J., Carvalho, A. F., Kubera, M., Murdjeva, M., & Maes, M. H. J. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00126-7 · Cited by 49
Self-citationMaes, M. H. J., Simeonova, D., Stoyanov, D., & Leunis, J. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.07.003 · Cited by 48
Self-citationFernández-Navarro, T., Salazar, N., Gutiérrez‐Díaz, I., Reyes‐Gavilán, C. G. D. L., Gueimonde, M., & González, S. (2017) · Nutrients · doi:10.3390/nu9060551 · Cited by 49
Mazereeuw, G., Herrmann, N., Bennett, S. A. L., Swardfager, W., Xu, H., Valenzuela, N., Fai, S., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.010 · Cited by 47
Wang, Y., Liu, X., Zhang, D., Chen, J., Liu, S., & Berk, M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-32 · Cited by 47
Self-citationDepression as a systemic disease
Sotelo, J. L., & Nemeroff, C. B. (2016) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2016.11.002 · Cited by 48
de Morais, C. R., Bonetti, A. M., Carvalho, S. M., de Rezende, A. A. A., Araujo, G. R., & Spanó, M. A. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.09.023 · Cited by 45
Oxidative stress and depressive symptoms in older adults: A magnetic resonance spectroscopy study
Duffy, S. L., Lagopoulos, J., Cockayne, N. L., Hermens, D. F., Hickie, I. B., & Naismith, S. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.007 · Cited by 44
Duarte-Silva, E. P., de Melo, M. G., Maes, M. H. J., Filho, A. J. M. C., Macêdo, D. S., & Peixoto, C. A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110351 · Cited by 45
Self-citationAndalib, S., Mashhadi-Mousapour, M., Bijani, S., & Hosseini, M.-J. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02761-0 · Cited by 43
Osler, M., Mårtensson, S., Wium‐Andersen, I. K., Prescott, E., Andersen, P. K., Jørgensen, T. S. H., Carlsen, K., Wium‐Andersen, M. K., & Jørgensen, M. B. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv227 · Cited by 42
Woo, Y. S., Lim, H. K., Wang, S., & Bahk, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186969 · Cited by 43
Gao, X., Liang, M., Fang, Y., Zhao, F., Tian, J., Zhang, X., & Qin, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00995 · Cited by 40
Mei, X., Xu, D., Xu, S., Zheng, Y., & Xu, S. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.075 · Cited by 38
Prothrombotic platelet phenotype in major depression: Downregulation by antidepressant treatment
López-Vílchez, I., Serra, M., Navarro, V., Hernández, M. R., Villalta, J., Díaz‐Ricart, M., Gastó, C., Escolar, G., & Galan, A. M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.022 · Cited by 40
Mazereeuw, G., Herrmann, N., Andreazza, A. C., Scola, G., David, W. L., OH, P. I., & Lanctôt, K. L. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.10.005 · Cited by 38
Sampaio, L. A. N. P. C., Fráguas, R., Lotufo, P. A., Benseñor, I. M., & Brunoni, A. R. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00087 · Cited by 38
Duffy, S. L., Lagopoulos, J., Cockayne, N. L., Lewis, S. J. G., Hickie, I. B., Hermens, D. F., & Naismith, S. L. (2015) · Nutrition · doi:10.1016/j.nut.2015.04.019 · Cited by 38
Oliveira, S. R., Kallaur, A. P., Lopes, J. M., Simão, A. N. C., Reiche, E. M. V., de Almeida, E. R. D., Morimoto, H. K., Pereira, W. L. D. C. J., Alfieri, D. F., Flauzino, T., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.12.039 · Cited by 37
Self-citationKeidser, G., & Seeto, M. (2017) · Trends in Hearing · doi:10.1177/2331216517706395 · Cited by 36
Trojan, E., Chamera, K., Bryniarska, N., Kotarska, K., Leśkiewicz, M., Regulska, M., & Basta‐Kaim, A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1458-1 · Cited by 37
Bortolasci, C. C., Vargas, H. O., Nunes, S. O. V., de Melo, de Castro, M. R. P., Moreira, E. G., Dodd, S., Barbosa, D. S., Berk, M., & Maes, M. H. J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.041 · Cited by 36
Self-citationC-reactive protein and cardiovascular risk in bipolar disorder patients: A systematic review
Marshe, V. S., Pira, S., Mantere, O., Bosche, B., Looper, K. J., Herrmann, N., Müller, D. J., & Rej, S. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.026 · Cited by 36
Mocking, R. J. T., Assies, J., Bot, M., Jansen, E. H. J. M., Schene, A. H., & Pouwer, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049431 · Cited by 35
de Morais, C. R., Carvalho, S. M., Naves, M. P. C., Araujo, G. R., de Rezende, A. A. A., Bonetti, A. M., & Spanó, M. A. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.08.108 · Cited by 33
Wang, Y., Xiao, Z., Liu, X., & Berk, M. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1177 · Cited by 33
Self-citationSahafi, E., Peeri, M., Hosseini, M.-J., & Azarbyjani, M. A. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.10.022 · Cited by 32
Lee, S.-Y., Lee, J. P., Lee, J., Park, J. Y., & Kim, E. Y. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110755 · Cited by 32
Mousa, R. F., Smesam, H. N., Qazmooz, H. A., Al‐Hakeim, H. K., & Maes, M. H. J. (2021) · CNS Spectrums · doi:10.1017/s1092852921000432 · Cited by 30
Self-citationFernández‐Montero, A., Moreno‐Galarraga, L., Sánchez‐Villegas, A., Lahortiga‐Ramos, F., Ruiz‐Canela, M., Martínez‐González, M. Á., & Molero, P. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02502-6 · Cited by 29
O'Neil, A. E., Williams, E. D., Stevenson, C., Oldenburg, B. F., Berk, M., & Sanderson, K. A. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-011-0421-5 · Cited by 29
Self-citationMeyer, T., Stanske, B., Kochen, M. M., Cordes, A., Yüksel, I., Wachter, R., Lüers, C., Scherer, M., Binder, L., Pieske, B. M., et al. (2011) · Behavioral Medicine · doi:10.1080/08964289.2011.609192 · Cited by 27
Muscle function loss is associated with anxiety in patients with gastrointestinal cancer.
Soares, J., Gomes, T. L., Siqueira, J. M., Oliveira, I. C. L., Mota, J., Laviano, A., & Pimentel, G. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.11.003 · Cited by 24
Moon, J. H., Kong, M. H., & Kim, H. J. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e320 · Cited by 27
Al‐Hakeim, H. K., Hadi, H. H., Jawad, G. A., & Maes, M. H. J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010023 · Cited by 28
Self-citationSomatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Rahola, J. G. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604533 · Cited by 28
Wang, S., Wang, J., Zhang, R., Wang, T., Yan, D., He, Z., Jiang, F., Hu, C., & Jia, W. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0662-7 · Cited by 26
Lambert, M., & Gressier, F. (2019) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719828970 · Cited by 27
Depressive Symptoms and Amyloid Pathology
Wiels, W. A., Oomens, J. E., Engelborghs, S., Baeken, C., Arnim, C. A. F. V., Boada, M., Didic, M., Dubois, B., Fladby, T., van der Flier, W. M., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.4305 · Cited by 25
No increase in inflammation in late-life major depression screened to exclude physical illness
Prak, E. T. L., Brooks, T. G., Makhoul, W., Beer, J. C., Zhao, L., Girelli, T., Skarke, C., & Sheline, Y. I. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01883-4 · Cited by 29
Comorbid depression in heart failure
Wallenborn, J., & Angermann, C. E. (2013) · Herz · doi:10.1007/s00059-013-3886-z · Cited by 24
Yoo, S., Kim, D., & Lim, H. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02179-3 · Cited by 25
Increased atherogenicity in mood disorders: a systematic review, meta-analysis and meta-regression
Jirakran, K., Almulla, A. F., Jaipinta, T., Vasupanrajit, A., Jansem, P., Tunvirachaisakul, C., Dzhambazova, E., Stoyanov, D., & Maes, M. H. J. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106005 · Cited by 23
Self-citationBrunoni, A. R., Machado‐Vieira, R., Sampaio-Júnior, B., Vieira, É. L. M., Valiengo, L. D. C. L., Benseñor, I. M., Lotufo, P. A., Carvalho, A. F., Cho, H. J., Gattaz, W. F., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.006 · Cited by 26
Vitamin D deficiency and depressive symptoms in the perinatal period
Lamb, A., Lutenbacher, M., Wallston, K. A., Pepkowitz, S. H., Holmquist, B., & Hobel, C. J. (2018) · Archives of Women s Mental Health · doi:10.1007/s00737-018-0852-z · Cited by 22
Yang, H., Lu, Y., Zeng, X., Li, L., Zhang, R., Ren, Z., & Liu, X. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/1275486 · Cited by 22
Liu, Y. L., Szklo, M., Davidson, K. W., Bathon, J. M., & Giles, J. T. (2015) · Arthritis Care & Research · doi:10.1002/acr.22635 · Cited by 21
Subjective well-being in non-obese individuals depends strongly on body composition
Chlabicz, M., Dubatówka, M., Jamiołkowski, J., Sowa, P., Łapińska, M., Raczkowski, A., Łaguna, W., Moniuszko-Malinowska, A. M., Waszkiewicz, N., Kowalska, I., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01205-6 · Cited by 21
Huang, P., Yan, L., Li, Z., Zhao, S., Feng, Y., Zeng, J., Chen, L., Huang, A., Chen, Y., Lei, S., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106450 · Cited by 21
Lanctôt, K. L., Mazereeuw, G., Herrmann, N., Xu, H., Blanchard, A. P., Figeys, D., OH, P. I., & Bennett, S. A. L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s87111 · Cited by 19
Fish oil as a management component for mood disorders – an evolving signal
Hegarty, B. D., & Parker, G. B. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835ab4a7 · Cited by 19
The role of immune abnormality in depression and cardiovascular disease.
Liu, R.-H., Pan, J., Tang, X., Li, B., Liu, S., & Ma, W. (2017) · PubMed · doi:10.11909/j.issn.1671-5411.2017.11.006 · Cited by 19
Investigating beta-endorphins: Ways to boost health, conventional and future detection methods
Ghosh, A., Chandra, R., Jain, U., & Chauhan, N. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2024.03.009 · Cited by 18
Qiu, L., Ren, Y., Li, J., Li, M., Li, W., Qin, L., Ning, C., Zhang, J., & Gao, F. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.139 · Cited by 18
Jirakran, K., Vasupanrajit, A., Tunvirachaisakul, C., Almulla, A. F., Kubera, M., & Maes, M. H. J. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06734-2 · Cited by 18
Self-citationHarvey, B. H., Hamer, M., Louw, R., van der Westhuizen, F. H., & Malan, L. (2012) · Neuropsychobiology · doi:10.1159/000343501 · Cited by 18
Metadata
- Authors
- Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M.
- Affiliations
- Piyavate Hospital (TH)
- Mental Health Research Institute (AU)
- Corresponding author
- Maes, Michael
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 35
- Issue
- 3
- Pages
- 769-783
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2011854518
- Cited by
- 169
- References
- 288
- Citations by year
- 2026: 4 · 2025: 17 · 2024: 10 · 2023: 9 · 2022: 8 · 2021: 7 · 2020: 13 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 13 · 2015: 15 · 2014: 12 · 2013: 12 · 2012: 12
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- major depressive disorder, cardiovascular disease, inflammatory signaling, oxidative stress, nitrosative stress, inflammatory cytokines, acute phase proteins, complement system, lipopolysaccharide, tryptophan catabolites, indoleamine 2,3-dioxygenase, antioxidants, atherosclerosis, omega-3 polyunsaturated fatty acids, cardiovascular mortality, Charlson Comorbidity Index
- MeSH terms
- Animals, Antioxidants, Cardiovascular Diseases, Depression, Female, Humans, Inflammation, Male, Risk, Fatty Acids, Omega-3, Nitrosation, Comorbidity, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review